.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Express Scripts
Julphar
Fuji
McKinsey
Accenture
QuintilesIMS
Cantor Fitzgerald
Queensland Health
Farmers Insurance

Drugs facing the most patent expirations this year

Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities.

Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril from loss of patent protection.

This chart shows which pharmaceutical companies face the most patent expirations this year.

The drug companies facing the most patent expirations this year are:

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the database preview and plans and pricing

botpot